GrafTech is a high-risk bet on graphite electrode recovery, with extended debt and pricing efforts offset by weak results.

TSMC cemented its global leadership in advanced chip manufacturing, driving strong revenue and profit growth amid surging AI ...

KalVista Pharmaceuticals faces a shrinking HAE market, tough competition, and launch uncertainty despite FDA approval. Read ...

Moncler's H1 2025 results were weak, but strong margins, brand strength, and a solid balance sheet support long-term value.

Enterprise Products Partners reports Monday with 15% growth expected, a 6.9% yield, safe 80% payout, and solid dividend ...

Owens Corning now trades below historical P/E levels with a strong dividend yield, growth, and buybacks boosting return ...

Edison International, one of California’s largest regulated utilities, is being mispriced by the market. Read why I am ...

Amkor Technology has rebounded after a steep drop, but headwinds and uncertain demand trends could spark another decline. See ...

High yield (5.23%), strong returns, & global diversification. Ideal for balanced investors seeking income & downside ...

UTEN offers reasonable expense ratios compared to similar-duration Treasury ETFs. Click here to read more on UTEN ETF and why ...

Northrim BanCorp is a regional bank focused on Alaska, with 90% of Q2 2025 revenue coming from net interest income. Read why ...

In Q2 2025, West Pharmaceutical's revenues increased by 9.17%, suggesting that the destocking effect is vanishing. Read why ...